Efficacy and Safety of Treatment With Ferric Carboxymaltose in Patients With Cirrhosis and Gastrointestinal Bleeding-Reference-Cited by-同舟云学术

Efficacy and Safety of Treatment With Ferric Carboxymaltose in Patients With Cirrhosis and Gastrointestinal Bleeding

Published:2020-04-17 Issue: Volume:7 Page:
ISSN:2296-858X
Container-title:Frontiers in Medicine
language:
Short-container-title:Front. Med.

Author:

Ballester-Clau Raquel,Torres Vicente Gisela,Cucala Ramos Mercedes,Aracil Blanch Carles,Miñana Calafat Josep Maria,Pijoan Comas Eva,Reñé Espinet Josep Maria,Planella de Rubinat Montse

Funder

Vifor Pharma

Publisher

Frontiers Media SA

Subject

General Medicine

Reference26 articles.

1. Burden of liver disease in Europe: epidemiology and analysis of risk factors to identify prevention policies;Pimpin;J Hepatol.,2018

2. Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases;Garcia-Tsao;Hepatology.,2017

3. Anemia and iron deficiency in gastrointestinal and liver conditions;Stein;World J Gastroenterol.,2016

4. Spectrum of anemia associated with chronic liver disease;Gonzalez-Casas;World J Gastroenterol.,2009

5. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Relationship between Circadian System Status, Child–Pugh Score, and Clinical Outcome in Cirrhotic Patients on Waiting Lists for Liver Transplantation;Journal of Clinical Medicine;2024-08-02

2. Randomized Controlled Trial of Intravenous Ferric Carboxymaltose vs Oral Iron to Treat Iron Deficiency Anemia After Variceal Bleed in Patients With Cirrhosis;American Journal of Gastroenterology;2024-05-14

3. Demir Karboksimaltoz Verilen Hastaların Değerlendirilmesi;Harran Üniversitesi Tıp Fakültesi Dergisi;2022-12-27

4. Management of iron‐deficiency anemia following acute gastrointestinal hemorrhage: A narrative analysis and review;Journal of Gastroenterology and Hepatology;2022-11-07

5. The investigation of the frequency of the alpha-1-antitrypsin phenotype in patients with liver cirrhosis;Hormone Molecular Biology and Clinical Investigation;2022-08-17